Literature DB >> 25385572

MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma.

Shoudan Zhang1, Qigui Qi.   

Abstract

Glioblastomas (GBMs) are the highest grade of primary brain tumors with astrocytic similarity and are characterized dispersal of tumor cell. Metastasis suppressor 1 (MTSS1) play an important role in cancer metastasis. Recent studies indicating that MTSS1 as a potential tumor suppressor and its reduced expression associated with poor prognosis in many cancer types. However, the relationship with the prognosis of patients and the molecular mechanism of MTSS1 renders a tumor suppressor effect in GBM is unknown. Here, we showed that low MTSS1 gene expression is associated with poor outcomes in patients with GBM. Overexpression of MTSS1 in U-87 MG cells exhibited inhibited glioma cell growth, colony formation, migration and invasion. Mechanistically, we found that high MTSS1 expression in U-87 MG reduced expression of CTTN. These results implicate that the role of MTSS1 suppresses cell migration and invasion by inhibiting expression of CTTN and as a prognosis biomarker in GBM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25385572     DOI: 10.1007/s11060-014-1656-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  MIM, a potential metastasis suppressor gene in bladder cancer.

Authors:  Young-Goo Lee; Jill A Macoska; Susan Korenchuk; Kenneth J Pienta
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

2.  Localization of cortactin is associated with colorectal cancer development.

Authors:  Hiroshi Hirakawa; Kenichiro Shibata; Toshiyuki Nakayama
Journal:  Int J Oncol       Date:  2009-12       Impact factor: 5.650

3.  [Effects of MIM-B gene on invasive and metastatic potentials of human hepatocellular carcinoma MHCC97H cells].

Authors:  Xiu-yan Huang; Zi-li Huang; Yong-hua Xu; Xin-yu Huang; Jian Zhou; Sheng-long Ye; Zhao-you Tang; Qi Zheng
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2010-12

4.  Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.

Authors:  Keita Nakane; Yasunori Fujita; Riyako Terazawa; Yuko Atsumi; Taku Kato; Yoshinori Nozawa; Takashi Deguchi; Masafumi Ito
Journal:  Int J Urol       Date:  2011-11-03       Impact factor: 3.369

5.  MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.

Authors:  H Fan; L Chen; F Zhang; Y Quan; X Su; X Qiu; Z Zhao; K L Kong; S Dong; Y Song; T H M Chan; X-Y Guan
Journal:  Oncogene       Date:  2011-09-12       Impact factor: 9.867

Review 6.  Roles of cortactin in tumor pathogenesis.

Authors:  László Buday; Julian Downward
Journal:  Biochim Biophys Acta       Date:  2007-01-09

7.  Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.

Authors:  Christian Parr; Wen G Jiang
Journal:  Eur J Cancer       Date:  2009-03-26       Impact factor: 9.162

Review 8.  Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?

Authors:  Shota Tanaka; David N Louis; William T Curry; Tracy T Batchelor; Jorg Dietrich
Journal:  Nat Rev Clin Oncol       Date:  2012-11-27       Impact factor: 66.675

9.  MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription.

Authors:  Christopher A Callahan; Tyler Ofstad; Lily Horng; Jordon K Wang; Hanson H Zhen; Pierre A Coulombe; Anthony E Oro
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

10.  Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B.

Authors:  Guillaume Bompard; Stewart J Sharp; Gilles Freiss; Laura M Machesky
Journal:  J Cell Sci       Date:  2005-11-15       Impact factor: 5.285

View more
  18 in total

1.  MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients.

Authors:  Wei Shi; Gulimire Hasimu; Yan Wang; Ning Li; Mingquan Chen; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

2.  miR-218 affects the ECM composition and cell biomechanical properties of glioblastoma cells.

Authors:  Małgorzata Grabowska; Konrad Kuczyński; Monika Piwecka; Alicja Rabiasz; Joanna Zemła; Paweł Głodowicz; Dariusz Wawrzyniak; Małgorzata Lekka; Katarzyna Rolle
Journal:  J Cell Mol Med       Date:  2022-06-15       Impact factor: 5.295

3.  Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.

Authors:  Jian Li; Yuxiang Chen; Xiong Guo; Ling Zhou; Zeming Jia; Yaping Tang; Ling Lin; Weidong Liu; Caiping Ren
Journal:  Tumour Biol       Date:  2016-01-07

4.  MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression.

Authors:  Ning Xu; Weiliang Yang; Yang Liu; Feng Yan; Zhange Yu
Journal:  Environ Sci Pollut Res Int       Date:  2018-02-16       Impact factor: 4.223

5.  MicroRNA-324-5p suppresses the migration and invasion of MM cells by inhibiting the SCFβ-TrCP E3 ligase.

Authors:  Lannan Zhang; Dong Liu; Bo Tang; Aoshuang Xu; Haifan Huang; Yan Su; Jian Xu; Jun Deng; Liang Tang; Chunyan Sun; Yu Hu
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

6.  MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4.

Authors:  T Zhan; C Cao; L Li; N Gu; C I Civin; X Zhan
Journal:  Leukemia       Date:  2016-02-29       Impact factor: 11.528

7.  Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.

Authors:  Rachel J Watkins; Waraporn Imruetaicharoenchoke; Martin L Read; Neil Sharma; Vikki L Poole; Erica Gentilin; Sukhchain Bansal; Emy Bosseboeuf; Rachel Fletcher; Hannah R Nieto; Ujjal Mallick; Allan Hackshaw; Hisham Mehanna; Kristien Boelaert; Vicki E Smith; Christopher J McCabe
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

8.  MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility.

Authors:  Daniel Luxen; Gerrit H Gielen; Anke Waha; Lukas Isselstein; Tim Müller; Philipp Koch; Jennifer Hammes; Albert Becker; Matthias Simon; Peter Wurst; Elmar Endl; Torsten Pietsch; Marco Gessi; Andreas Waha
Journal:  Transl Oncol       Date:  2016-12-15       Impact factor: 4.243

9.  Understanding cytoskeleton regulators in glioblastoma multiforme for therapy design.

Authors:  Samaneh Masoumi; Aditya Harisankar; Aileen Gracias; Fabian Bachinger; Temesgen Fufa; Gayathri Chandrasekar; Frank Gaunitz; Julian Walfridsson; Satish S Kitambi
Journal:  Drug Des Devel Ther       Date:  2016-09-12       Impact factor: 4.162

10.  Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated.

Authors:  Candelaria Bracalente; Irene L Ibañez; Ariel Berenstein; Cintia Notcovich; María B Cerda; Fabio Klamt; Ariel Chernomoretz; Hebe Durán
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.